Collective review
The lowest medication price on this masthead by a wide margin, and a headline that still leaves something out. Compounded semaglutide is $59 a month and tirzepatide $69, flat at every dose and cancellable whenever you like — but both require a $199 annual membership that the pricing line never mentions. Counted honestly the first year comes to $907 for semaglutide, about $76 a month, and $1,027 for tirzepatide, about $86, which stays among the cheapest anywhere even after the fee. It is run by Health For Everyone Inc., trading as CollectiveOS, and sells itself on being brought to you by the founder of Thrive Market and on GLP-1s without the 500% markup. There is a 21-day free trial before the membership is charged; after that the fee is non-refundable and no partial periods are returned. The compounding pharmacies are described only as independent third-party licensed pharmacies and never named, and no state list is published.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Collective at a glance
- Semaglutide
- $59/mo plus a required membership
- Tirzepatide
- $69/mo plus a required membership
- Coverage
- Not published
- Brand-name
- Compounded only
How we scored Collective
Each score comes out of Collective's published pricing, disclosures and oversight, and the six combine into the 50/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair value once you read past any teaser rate or plan structure.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- September 2026
- Confidence
- medium
- Primary source
- www.collective.org
Genuinely the cheapest medication on this masthead, and the headline still understates the bill. Compounded semaglutide is $59 a month and tirzepatide $69, flat at every dose, cancel anytime — but both require a $199 annual membership the pricing line leaves out. Counted properly the first year is $907 and $1,027, about $76 and $86 a month, which remains among the lowest anywhere. It comes from the founder of Thrive Market and sells itself on stripping out the markup. The membership fee is non-refundable, partial periods are not refunded, and the pharmacies are never named.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $59 | Any dose, flat⛔ EXCLUDES A REQUIRED FEE. The site states "$59/month + $199 annual membership", so the first year totals $907 — about $76 a month once the membership is counted. |
| Compounded tirzepatide | $69 | Any dose, flat⛔ Also excludes the membership. "The cost is $69/month + $199 annual membership" — a first-year total of $1,027, about $86 a month. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Collective's public disclosures at last review and change often; confirm the current number on Collective's own site.
What we like
- The lowest medication prices on this masthead, $59 and $69 a month, flat at every dose
- Still among the cheapest anywhere once the membership is counted properly
- A 21-day free trial before the membership fee is charged
- Cancel anytime, with no recurring monthly fee beyond the medication
- Names its operating company, Health For Everyone Inc., in its own terms
The caveats
- The advertised $59 and $69 exclude a mandatory $199 annual membership
- Counted properly the first year is $907 for semaglutide and $1,027 for tirzepatide
- Membership fees are non-refundable and no partial-period refunds are given
- Compounding pharmacies are never named
- State availability is not published on the marketing site
- Nothing addresses pregnancy, breastfeeding or postpartum timing
Collective for mothers: our verdict
The lowest medication price on this masthead by a wide margin, and a headline that still leaves something out. Compounded semaglutide is $59 a month and tirzepatide $69, flat at every dose and cancellable whenever you like — but both require a $199 annual membership that the pricing line never mentions. Counted honestly the first year comes to $907 for semaglutide, about $76 a month, and $1,027 for tirzepatide, about $86, which stays among the cheapest anywhere even after the fee. It is run by Health For Everyone Inc., trading as CollectiveOS, and sells itself on being brought to you by the founder of Thrive Market and on GLP-1s without the 500% markup. There is a 21-day free trial before the membership is charged; after that the fee is non-refundable and no partial periods are returned. The compounding pharmacies are described only as independent third-party licensed pharmacies and never named, and no state list is published.
We weigh Collective the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Collective actually costs
- Compounded semaglutide — Any dose, flat: $59/mo
- Compounded tirzepatide — Any dose, flat: $69/mo
The medications Collective prescribes
Collective prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Collective fits — and where it doesn't — for mothers
Worth it if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Collective is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A household where the monthly number is the constraint, and someone who will count the annual membership into the first-year total before comparing.
Alternatives to Collective
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Collective
Head-to-head & alternatives
Collective, answered
- Is it really $59 a month?
- Not by itself. The $59 covers the medication, and Collective's own FAQ adds "+ $199 annual membership" — a fee the headline leaves out. Counting it, the first year is $907 for semaglutide, about $76 a month, and $1,027 for tirzepatide, about $86. Those are still among the lowest numbers on this masthead; they are simply not the ones on the front page.
- Is the membership refundable?
- No. Membership fees are non-refundable and no partial-period refunds are given. There is a 21-day free trial before the fee is charged, so the real decision point is the end of that trial. After it, canceling stops future medication charges but does not return the $199.
- Does the price climb with the dose?
- No. Collective states "Same price, every dose" for both molecules, so titrating up does not raise the medication charge. Flat dose pricing is uncommon enough to be worth weighing, especially if you expect to settle on a higher maintenance dose.
- Who compounds the medication?
- Collective does not say. Its pages describe "independent, third-party licensed pharmacies" without naming any of them, so there is nothing to look up. It also does not publish which states it serves.
Pricing, states and verification reflect Collective's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.